Dr. Reddy's Laboratories
RDY
#1699
Rank
S$15.38 B
Marketcap
S$18.39
Share price
0.35%
Change (1 day)
-4.47%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$2.62 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total liabilities are S$2.62 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dr. Reddy's Laboratories - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31S$2.44 B41.62%
2024-03-31S$1.72 B17.57%
2023-03-31S$1.47 B-19.41%
2022-03-31S$1.82 B7.47%
2021-03-31S$1.69 B16.47%
2020-03-31S$1.45 B-12.29%
2019-03-31S$1.66 B-16.75%
2018-03-31S$1.99 B-3.18%
2017-03-31S$2.06 B27.76%
2016-03-31S$1.61 B-12.25%
2015-03-31S$1.83 B10.41%
2014-03-31S$1.66 B4.74%
2013-03-31S$1.59 B3.74%
2012-03-31S$1.53 B10.34%
2011-03-31S$1.38 B18.54%
2010-03-31S$1.17 B-6.57%
2009-03-31S$1.25 B-4.77%
2008-03-31S$1.31 B-15.62%
2007-03-31S$1.56 B-7.72%
2006-03-31S$1.69 B432.37%
2005-03-31S$0.31 B47.56%
2004-03-31S$0.21 B36.58%
2003-03-31S$0.15 B18.94%
2002-03-31S$0.13 B-48.4%
2001-03-31S$0.25 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
S$149.85 B 5,609.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$42.24 B 1,509.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$79.41 B 2,926.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
S$81.04 B 2,987.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$85.56 B 3,160.23%๐Ÿ‡ซ๐Ÿ‡ท France